# Study to Investigate the Absolute Bioavailability of Oral Sylibin

> **NCT02633696** · PHASE1 · COMPLETED · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** silybin phosphatidylcholine
- **DRUG:** Legalón SIL

## Key facts

- **NCT ID:** NCT02633696
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-11
- **Final completion:** 2014-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633696, "Study to Investigate the Absolute Bioavailability of Oral Sylibin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02633696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*